
API and parent drug
Dinoprostone
CAS 363-24-6 · C20H32O5 · 15 related records
01API identity and structure

| API / medicine name | Dinoprostone |
|---|---|
| CAS RN | 363-24-6 |
| PubChem CID | 5280360 |
| Molecular formula | C20H32O5 |
| Molecular weight | 352.47 g/mol |
| IUPAC name | (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid |
| Defined stereocentres | 4 |
| Unassigned stereocentres | 0 |
| SMILES | CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O |
|---|---|
| InChI | Not listed |
| InChIKey | XEYBRNLFEZDVAW-ARSRFYASSA-N |
02Stereochemistry
The published structure contains 4 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.
Published same-connectivity configurations
5 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.




Dinoprostone EP Impurity A (Free Base)
CAS 38873-82-4
XEYBRNLFEZDVAW-GKEZHNTDSA-N
4 defined, 0 unassigned centres

Dinoprostone EP Impurity B (Free Base)
CAS 27415-25-4
XEYBRNLFEZDVAW-CLQOMRTCSA-N
4 defined, 0 unassigned centres
Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
03Structural nitrosamine screen
No record-level structural candidate is currently published for this identity.
This result does not predict manufacturing conditions, formation, analytical findings or absence of risk. A process-specific assessment is required.
04India status for this compound
The result below applies only to this exact compound identity and CAS number.
| NDPS / RCS | NOT FOUND IN REVIEWED ENTRIES | No exact reviewed identity entry was found. Generic, class, analogue, salt and isomer provisions were not evaluated. Confirm the current official schedule before a regulatory decision. |
|---|---|---|
| SCOMET | NOT FOUND IN REVIEWED CAS ENTRIES | CAS 363-24-6 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · source version 1985-09-16
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · source version 2026-03-11
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · source version 2024-09-02
06Sources
- S01PubChem compound record, CID 5280360
Structure, identifiers and machine-readable properties for the API identity.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. Vendor descriptions and contributed narrative text are not reproduced.
- S03Lazychem chemical records
Parent-family links use the supplied parent identity.












